Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Moodys
McKinsey
Federal Trade Commission
Daiichi Sankyo
Cipla
QuintilesIMS
Medtronic
Teva

Generated: December 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020511

« Back to Dashboard

NDA 020511 describes APHTHASOL, which is a drug marketed by Uluru and is included in one NDA. Additional details are available on the APHTHASOL profile page.

The generic ingredient in APHTHASOL is amlexanox. Additional details are available on the amlexanox profile page.
Summary for 020511
Tradename:APHTHASOL
Applicant:Uluru
Ingredient:amlexanox
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:PASTE;DENTALStrength5%
Approval Date:Dec 17, 1996TE:RLD:No

Expired US Patents for NDA 020511

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Uluru APHTHASOL amlexanox PASTE;DENTAL 020511-001 Dec 17, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
Daiichi Sankyo
Medtronic
Julphar
Cantor Fitzgerald
Baxter
Cerilliant
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.